Determination of Alzheimer's Disease Stages by Artificial Learning Algorithms

Authors

  • Nurgul Bulut Department of Biostatistics and Medical Informatics, Faculty of Medicine, Istanbul Medeniyet University, 34000, Istanbul, Turkey
  • Tuna Cakar Department of Computer Engineering, Faculty of Engineering, MEF University, 34396, Istanbul, Turkey
  • Ilker Arslan Department of Mechanical Engineering, Faculty of Engineering, MEF University, 34396, Istanbul, Turkey
  • Zeynep K. Akinci Department of Neurology, Sultan Abdulhamid Han Research and Training Hospital, Saglik Bilimleri University, 34668, Istanbul, Turkey
  • Kevser S. Oner Department of Biostatistics, Faculty of Medicine, Eskisehir Osmangazi University, 26040, Eskisehir, Turkey

DOI:

https://doi.org/10.6000/1929-6029.2025.14.50

Keywords:

Alzheimer's Disease, Artificial Intelligence, National Alzheimer's Coordinating Center, Machine Learning, Explainable Artificial Intelligence, SHapley Addictive exPlanations, Artificial Learning Algorithm

Abstract

Introduction: This study aims to determine the stages of Alzheimer's disease (AD) using different machine learning algorithms, and compares the performance of these models.

Methods: Demographic, genetic, and neurocognitive inventory data from the National Alzheimer's Coordinating Center (NACC) database as well as brain volume/thickness data from magnetic resonance imaging (MRI) scans were used. Deep Neural Networks, Ordinal Logistic Regression, Random Forest, Gaussian Naive Bayes, XGBoost, and LightGBM models were used to identify four different ordinal stages of AD.

Results: Although the performance measures of the developed models were similar, the highest classification rate of AD stages was achieved by the Random Forest model (accuracy: 0.86; F1 score: 0.86; AUC: 0.95). The outputs of the model with the best performance were explained by the SHapley Addictive exPlanations (SHAP) method.

Conclusions: This indicates that non-invasive markers and machine learning models can be used effectively in early diagnosis and decision support systems to predict stages of AD.

References

Alıcılar HE, Çalışkan D. Alzheimer's disease and prevention strategies. J Contin Med Educ 2021; 30(2): 107-15.

United Nations. World Population Prospects 2024: Summary of Results [Internet]. New York: United Nations; 2024 [cited 2024]. Available from: https://www.un.org/development/desa/ pd/content/World-Population-Prospects-2024.

Alzheimer’s Association 2024 Alzheimer's disease facts and figures. Alzheimers Dement 2024; 20(5): 3708-21. DOI: https://doi.org/10.1002/alz.13809

Mavioğlu H. Alzheimer's disease. In: Behavioral Neurology. 2nd ed. Istanbul: Nobel Medical Bookstores 2020; pp. 145-72.

Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010; 9(1): 119-28. DOI: https://doi.org/10.1016/S1474-4422(09)70299-6

Hoşgör H, Güngördü H. A qualitative research on the uses of artificial intelligence in health. Eur J Sci Technol 2022; (35): 395-407.

Besser LM, Kukull WA, Teylan MA, Bigio EH, Cairns NJ, Kofler JK, et al. The revised National Alzheimer's Coordinating Center's Neuropathology Form-available data and new analyses. J Neuropathol Exp Neurol 2018; 77(8): 717-26. DOI: https://doi.org/10.1093/jnen/nly049

Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J, et al. The National Alzheimer's Coordinating Center (NACC) database: the uniform data set. Alzheimers Dis Assoc Disord 2007; 21(3): 249-58. DOI: https://doi.org/10.1097/WAD.0b013e318142774e

Gürvit İH, Baran B. Scales in dementias and cognitive disorders. Arch Neuropsychiatry 2007; 44(2): 58-65.

Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging. Alzheimers Dement 2013; 9(5): 529-37. DOI: https://doi.org/10.1016/j.jalz.2012.10.001

Manca R, Correro AN, Gauthreaux K, Flatt JD. Divergent patterns of cognitive deficits and structural brain alterations between older adults in mixed-sex and same-sex relationships. Front Hum Neurosci 2022; 16: 620. DOI: https://doi.org/10.3389/fnhum.2022.909868

Kovacevic S, Rafii MS, Brewer JB. High-throughput, fully-automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. Alzheimers Dis Assoc Disord 2009; 23(2): 139. DOI: https://doi.org/10.1097/WAD.0b013e318192e745

Tangaro S, Fanizzi A, Amoroso N, Bellotti R, Alzheimer's Disease Neuroimaging Initiative. A fuzzy-based system reveals Alzheimer's disease onset in subjects with mild cognitive impairment. Phys Med 2017; 38: 36-44. DOI: https://doi.org/10.1016/j.ejmp.2017.04.027

Mungas D, Reed BR, Jagust WJ, DeCarli C, Mack WJ, Kramer JH, et al. Volumetric MRI predicts the rate of cognitive decline related to AD and cerebrovascular disease. Neurology 2002; 59(6): 867-73. DOI: https://doi.org/10.1212/WNL.59.6.867

Roweis ST, Saul LK. Nonlinear dimensionality reduction by locally linear embedding. Science 2000; 290(5500): 2323-6. DOI: https://doi.org/10.1126/science.290.5500.2323

Yang H, Oh CK, Amal H, Wishnok JS, Lewis S, Schahrer E, et al. Mechanistic insight into female predominance in Alzheimer's disease based on aberrant protein S-nitrosylation of C3. Sci Adv 2022; 8(50): eade0764. DOI: https://doi.org/10.1126/sciadv.ade0764

Yang W, Lui RL, Gao JH, Chan TF, Yau ST, Sperling RA, et al. Independent component analysis-based classification of Alzheimer's disease MRI data. J Alzheimers Dis 2011; 24(4): 775-83. DOI: https://doi.org/10.3233/JAD-2011-101371

Zhang D, Wang Y, Zhou L, Yuan H, Shen D, Alzheimer's Disease Neuroimaging Initiative. Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage 2011; 55(3): 856-67. DOI: https://doi.org/10.1016/j.neuroimage.2011.01.008

Wolz R, Julkunen V, Koikkalainen J, Niskanen E, Zhang DP, Rueckert D, et al. Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease. PLoS One 2011; 6(10): e25446. DOI: https://doi.org/10.1371/journal.pone.0025446

Liu S, Liu S, Cai W, Che H, Pujol S, Kikinis R, et al. Multimodal neuroimaging feature learning for multiclass diagnosis of Alzheimer's disease. IEEE Trans Biomed Eng 2014; 62(4): 1132-40. DOI: https://doi.org/10.1109/TBME.2014.2372011

Ritter K, Schumacher J, Weygandt M, Buchert R, Allefeld C, Haynes JD, et al. Multimodal prediction of conversion to Alzheimer's disease based on incomplete biomarkers. Alzheimers Dement Diagn Assess Dis Monit 2015; 1(2): 206-15. DOI: https://doi.org/10.1016/j.dadm.2015.01.006

Khagi B, Kwon GR, Lama R. Comparative analysis of Alzheimer's disease classification by CDR level using CNN, feature selection, and machine-learning techniques. Int J Imaging Syst Technol 2019; 29(3): 297-310. DOI: https://doi.org/10.1002/ima.22316

Liu M, Li F, Yan H, Wang K, Ma Y, Shen L, et al. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease. Neuroimage 2020; 208: 116459. DOI: https://doi.org/10.1016/j.neuroimage.2019.116459

Liu J, Li M, Luo Y, Yang S, Li W, Bi Y. Alzheimer's disease detection using depthwise separable convolutional neural networks. Comput Methods Programs Biomed 2021; 203: 106032. DOI: https://doi.org/10.1016/j.cmpb.2021.106032

González DA, Gonzales MM, Jennette KJ, Soble JR, Fongang B. Cognitive screening with functional assessment improves diagnostic accuracy and attenuates bias. Alzheimers Dement Diagn Assess Dis Monit 2021; 13(1): e12250. DOI: https://doi.org/10.1002/dad2.12250

Al Olaimat M, Martinez J, Saeed F, Bozdag S. PPAD: A deep learning architecture to predict progression of Alzheimer's disease. bioRxiv 2023. DOI: https://doi.org/10.1101/2023.01.28.526045

Downloads

Published

2025-09-01

How to Cite

Bulut, N. ., Cakar, T. ., Arslan, I. ., Akinci, Z. K. ., & Oner, K. S. . (2025). Determination of Alzheimer’s Disease Stages by Artificial Learning Algorithms. International Journal of Statistics in Medical Research, 14, 532–542. https://doi.org/10.6000/1929-6029.2025.14.50

Issue

Section

Special Issue: Trends in Artificial Intelligence and Machine Learning in Healthcare